LoginRegister
    AstraZeneca CKD anaemia drug Roxadustat shows increased haemoglobin levels in Phase 3 trialAstraZeneca CKD anaemia drug Roxadustat shows increased haemoglobin levels in Phase 3 trial
    Crescita Therapeutics gets USFDA nod for Enhanced Formulation of PliaglisCrescita Therapeutics gets USFDA nod for Enhanced Formulation of Pliaglis
    Medical Representatives to now work 8 hours a day, get proper overtime: TN Govt OrderMedical Representatives to now work 8 hours a day, get proper overtime: TN Govt Order
    Shilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVAShilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVA
    Johnson and Johnson seeks European Medicines Agency nod for Ebola VaccineJohnson and Johnson seeks European Medicines Agency nod for Ebola Vaccine
    Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakhPenalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh
    Fortis Healthcare reports net profit of Rs 124 crore for September quarterFortis Healthcare reports net profit of Rs 124 crore for September quarter
    Juul Labs to pull back sales of mint-flavoured nicotine pods in USJuul Labs to pull back sales of mint-flavoured nicotine pods in US
    CDSCO to regulate Adhesives for fixing wigs, scalp cleansing products, artificial nails system, invites commentsCDSCO to regulate Adhesives for fixing wigs, scalp cleansing products, artificial nails system,...
    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in troubleNew USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble
    Aurobindo Pharma gets 8 USFDA observations for 2 facilities in HyderabadAurobindo Pharma gets 8 USFDA observations for 2 facilities in Hyderabad
    Novartis arm wins USFDA nod for biosimilar Ziextenzo in oncology careNovartis arm wins USFDA nod for biosimilar Ziextenzo in oncology care
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X